Table 1.
Demographic and clinical data about the PsA and GoA patients.
| Variables | Groups | p | |
|---|---|---|---|
| PsA Patients | GoA Patients | ||
| (n = 156) | (n = 50) | ||
| Age (years) | |||
| Mean ± SD | 54.36 ± 13.55 | 62.46 ± 11.55 | <0.001 t |
| Sex n (%) | |||
| Women | 63 (40.40%) | 25 (50%) | |
| Men | 93 (59.60%) | 25 (50%) | 0.253 f |
| BMI | 31.40 ± 5.44 | 28.36 ± 4.33 | <0.001 t |
| Comorbidity n (%) | |||
| Hypertension | 112 (71.70%) | 41(82.00%) | 0.193 f |
| Diabetes | 125 (80.12%) | 13 (26.00%) | <0.001 f |
| Ischemic h.d. | 61 (39.10%) | 9 (18.00%) | 0.006 f |
| Hyperuricemia | 111 (71.15%) | 3 (6.0%) | <0.001 f |
| Dyslipidemia | 99 (63.46%) | 13 (26.00%) | <0.001 f |
| Obesity | 132 (84.60%) | 25 (50.00%) | <0.001 f |
| Synovial fluid crystals n (%) | 37 (23.70%) | 0 (0.00%) | <0.001 f |
t—independent samples t-test; f—Fisher’s exact test.